Sodium tanshinone IIA sulfate reduces elevated serum high sensitivity C-reactive protein in patients with coronary heart disease: A prospective randomized open-label blinded end point trial

Authors
Category Primary study
JournalJournal of the American College of Cardiology
Year 2014
This article has no abstract
Epistemonikos ID: 9303d2065a49fa8a7695fb6676c3f6e43b4ac46a
First added on: Feb 06, 2025